Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: CBT raises $9.8M in series A

    Cancer company CBT Pharmaceuticals Inc. (Santa Clara, Calif.) raised $9.8 million in a series A round led by OrbiMed Asia. CBT's parent company is CRO Crown Bioscience International Inc. (TPex-E:6554), which seeded the …

    Published on 8/30/2016
  • FINANCIAL NEWS: Arcus discloses $119.7M in financings

    Immuno-oncology company Arcus Biosciences (Hayward, Calif.) emerged from stealth mode and disclosed it has raised $119.7 million raised in combined series A and B rounds. CEO Terry Rosen told BioCentury the company …

    Published on 8/29/2016
  • FINANCIAL NEWS: Cancer diagnostic play Mitra raises $27.4M

    Mitra Biotech Inc. (Boston, Mass.) raised $27.4 million in a series B round led by Sequoia India and Sands Capital Ventures. Other investors included RA Capital Management and existing investors Accel Partners and Tata …

    Published on 8/29/2016
  • FINANCIAL NEWS: Sofinnova Ventures raising $650M fund

    Sofinnova Ventures has raised $595.5 million toward Sofinnova Venture Partners X, its planned $650 million tenth fund, according to an SEC filing.Sofinnova closed its prior fund at $500 million in July 2014. The ninth …

    Published on 8/25/2016
  • FINANCIAL NEWS: Clarus co-founder Steinmetz passes away

    Clarus co-founder and Managing Director Michael Steinmetz passed away Aug. 6 from heart failure due to familial dilated cardiomyopathy, a heritable condition.In a notice posted on its website, Clarus said Steinmetz's …

    Published on 8/23/2016
  • FINANCIAL NEWS: Sophiris sinks after pricing discounted follow-on

    Sophiris Bio Inc. (NASDAQ:SPHS) raised $26 million through the sale of 6.5 million units at $4 in a follow-on underwritten by Piper Jaffray and Maxim. Each unit includes a share plus a warrant to acquire 0.75 shares. …

    Published on 8/23/2016
  • FINANCIAL NEWS: ABLS spinout raises $15M in series A round

    Allied Minds plc (LSE:ALM) said fibrosis and autoimmune start-up ABLS II LLC raised $15 million in a series A round. ABLS II is among three companies spun out from joint venture Allied-Bristol Life Sciences LLC, which …

    Published on 8/22/2016
  • FINANCIAL NEWS: Genomics company Singlera raises $20M

    Singlera Genomics Inc. (La Jolla, Calif.) raised $20 million in a series A round led by Lilly Asia Ventures. Green Pine Capital Partners and CDBI Partners also participated. The company is developing non-invasive …

    Published on 8/22/2016
  • FINANCIAL NEWS: Vyome's series C round brings in $14M

    Vyome Biosciences Pvt. Ltd. (New Delhi, India) raised $14 million in a series C round led by Perceptive Advisors and Romulus Capital. Existing investors including Kalaari Capital, Sabre Partners and Aarin Capital also …

    Published on 8/22/2016
  • FINANCIAL NEWS: Cambridge Innovation raises L75M

    Cambridge Innovation Capital plc raised L75 million ($97 million) in a private placement that included new investors Woodford Investment Management, Winton Ventures and the Oman Investment Fund. Existing shareholders …

    Published on 8/19/2016
  • FINANCIAL NEWS: Avelas' series C round brings in $20M

    Avelas Biosciences Inc. (La Jolla, Calif.) raised $20 million in a series C financing led by the Pharmstandard International S.A. subsidiary of Pharmstandard OJSC (RTS:PHST; LSE:PHST). New investors Ervington …

    Published on 8/18/2016
  • FINANCIAL NEWS: Nutrinia raises $30M in series D round

    Nutrinia Ltd. (Ramat Gan, Israel) raised $30 million in a series D round led by new investor TPG Biotech. New investors H.I.G. BioHealth Partners and WuXi Healthcare Ventures also participated, as did existing investors…

    Published on 8/18/2016
  • FINANCIAL NEWS: OncoMed raises $55M in follow-on

    Cancer stem cell company OncoMed Pharmaceuticals Inc. (NASDAQ:OMED) raised $55 million through the sale of 5.5 million shares at $10 in a follow-on underwritten by Leerink, Wells Fargo and JMP Securities. The company …

    Published on 8/18/2016
  • FINANCIAL NEWS: Advaxis raises $30M in direct offering

    Advaxis Inc. (NASDAQ:ADXS) raised $30 million through the sale of about 2.2 million shares at $13.50 in a registered direct offering with undisclosed institutional investors. The deal price is a 9% discount to Advaxis' …

    Published on 8/16/2016
  • FINANCIAL NEWS: Arrowhead names investors in $45M private placement

    On Friday, Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) said OrbiMed, RA Capital, Perceptive Advisors and RTW Investments were among the institutional investors in a private placement the company priced Tuesday before …

    Published on 8/12/2016
  • FINANCIAL NEWS: Amarin, Omeros fall after follow-ons

    Shares of Amarin Corp. plc (NASDAQ:AMRN) and Omeros Corp. (NASDAQ:OMER) both slipped on Thursday after the companies priced follow-ons. Amarin raised $60.1 million through the sale of 21.1 million ADSs at $2.85. Each …

    Published on 8/11/2016
  • FINANCIAL NEWS: GV's Maris steps down

    GV, the venture arm of Google Inc. parent Alphabet Inc. (NASDAQ:GOOG), said CEO Bill Maris is leaving the firm. Managing Director David Krane will succeed Maris, who had led GV since its 2009 launch. In a statement, the…

    Published on 8/11/2016
  • FINANCIAL NEWS: Metabolon raises $15M in series E

    Metabolon Inc. (Durham, N.C.) raised a $15 million series E round. Metabolon said the round's sole investor, Essex Woodlands, may invest an additional $10 million, which Metabolon would use to buy back shares from …

    Published on 8/11/2016
  • FINANCIAL NEWS: Acadia raises $200M in follow-on

    Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) raised $200 million through the sale of 6.1 million shares at $33 in a follow-on underwritten by JPMorgan, Goldman Sachs, BofA Merrill Lynch, Cowen, Piper Jaffray and Needham. …

    Published on 8/10/2016
  • FINANCIAL NEWS: Myriad sags following FY17 guidance

    Molecular diagnostics company Myriad Genetics Inc. (NASDAQ:MYGN) fell $9.76 (33%) to $19.70 on Wednesday after the company provided FY17 revenue guidance that missed the consensus estimate. Myriad expects FY17 revenues …

    Published on 8/10/2016
  • FINANCIAL NEWS: BioMarin raises $720M in follow-on

    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) raised $720 million through the sale of 7.5 million shares at $96 in a follow-on underwritten by Goldman Sachs and BofA Merrill Lynch.The company said it would use the funds …

    Published on 8/9/2016
  • FINANCIAL NEWS: Financial tracks

    Debra Yu joined China Renaissance as managing director and head of cross-border healthcare investment banking, based in the Beijing investment bank's New York office. Yu was managing director at life sciences advisory …

    Published on 8/8/2016
  • FINANCIAL NEWS: Pain play PixarBio looks to raise up to $30M

    Pain company PixarBio Corp. (Medford, Mass.) said it is in the process of merging with an undisclosed public entity and plans to raise $20-$30 million in a PIPE. The company expects to be publicly traded on the OTCQB by…

    Published on 8/8/2016
  • FINANCIAL NEWS: Ambrx raises $45M

    Ambrx Inc. (San Diego, Calif.) said it raised $45 million in a financing round led by Apricot Capital and Northeast Securities Prosperity Healthcare Fund. Sinopharm Capital, Humanwell Healthcare Fund, Fosun Capital, …

    Published on 8/4/2016
  • FINANCIAL NEWS: Exelixis' first Cabometyx sales beat expectations

    Exelixis Inc. (NASDAQ:EXEL) jumped $1.68 (18%) to $11.07 on Thursday after reporting sales of newly launched renal cell carcinoma (RCC) drug Cabometyx cabozantinib that beat analysts' estimates. Sales of Cabometyx were…

    Published on 8/4/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993